Neuroendocrine tumors other imaging findings

Neuroendocrine tumors Microchapters
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Epidemiology and Demographics
Risk factors
Natural History, Complications and Prognosis
History and Symptoms
Laboratory Findings
CT scan
PET scan
Medical Therapy
Surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Other Imaging Findings

The diagnostic procedure that utilizes a somatostatin analog is the OctreoScan, also called somatostatin receptor scintigraphy (SRS or SSRS): a patient is injected with octreotide chemically bound to a radioactive substance, often indium-111; for those patients whose tumor cells are avid for octreotide, a radiation-sensitive scan can then indicate the locations of the larger lesions.